Magnesium and fasting glucose in older adults: a nuanced look at a targeted intervention
A rigorously designed trial suggests that adding magnesium can lower fasting blood sugar in older adults who are magnesium-deficient, but reversing the trajectory toward diabetes likely requires more than fixing a single mineral.
Study at a glance: Oral magnesium supplementation improves glycemic control in older Chinese adults with pre-diabetes and hypomagnesemia: a randomized controlled trial (https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2026.1765308/full).
Prediabetes sets a critical stage where blood glucose is elevated but not yet in the diabetes range. The new Frontiers in Nutrition study explores whether magnesium supplementation can meaningfully improve glucose control in this group, especially among older adults who also have low magnesium levels.
Why magnesium matters
Prediabetes offers a window of opportunity for prevention. Magnesium deficiency is common in older populations and has been linked to impaired glucose metabolism and insulin resistance. Biologically, magnesium acts as a cofactor for many enzymes involved in glucose processing and insulin signaling, so restoring adequate magnesium could potentially improve metabolic function.
Previous research on magnesium supplementation in prediabetes has been limited. Only two small randomized trials exist, and neither specifically enrolled magnesium-deficient individuals or tightly tracked dietary magnesium, which may help explain inconsistent results.
Older adults may be particularly susceptible to both prediabetes and magnesium deficiency due to age-related changes in nutrient absorption. This study specifically targeted that demographic.
What the trial did
- Participants: 71 older Chinese adults (average age about 69) with prediabetes and magnesium deficiency.
- Design: Exploratory randomized controlled trial over 16 weeks.
- Intervention: Daily 360 mg of elemental magnesium as magnesium oxide, taken with a meal, versus a placebo.
- Completion: 65 participants finished the study.
What was measured
Researchers focused on fasting glucose (the primary outcome) from baseline to four months. They also tracked insulin, C-peptide, and insulin resistance via the HOMA-IR index, a common proxy for hepatic insulin resistance. Additional markers included HbA1c, glycated albumin, and inflammatory indicators such as hs-CRP and IL-6. Dietary magnesium intake was monitored to ensure changes in intake didn’t confound results.
Key findings
- Magnesium status rose more in the supplement group than in the placebo group, with an adjusted mean difference of about 0.056 mmol/L.
- Fasting glucose declined modestly in the magnesium group, with an adjusted difference of roughly -0.5 mmol/L.
- HbA1c and other non-fasting glucose measures did not show meaningful changes between groups, suggesting the fasting glucose improvement did not translate into a broad, sustained glycemic improvement over the 16 weeks.
- The observed glucose improvement aligns with an earlier similar study, but other research has shown mixed results. The authors emphasize that benefits appeared mainly in participants who started with low magnesium levels.
Adherence and safety
- About 92% of participants followed the intervention protocol, and there were no adverse events attributed to the magnesium supplementation.
- Dietary intake remained stable, which strengthens confidence that observed effects were linked to the supplementation rather than dietary changes.
A note on dose and form
- Magnesium oxide was used in this study, which is known to have relatively lower bioavailability compared to forms like magnesium citrate or glycinate. The limited bioavailability may have tempered potential effects. The modest magnesium rise and small glycemic shift could reflect this formulation choice.
Interpreting the results
- Strengths: A well-controlled randomized design, ongoing tracking of dietary magnesium, and exploratory metabolomics to capture broader metabolic shifts.
- Limitations: Small sample size, making the trial underpowered for most outcomes. Fasting glucose was the sole dynamic glycemic measure used rather than postprandial glucose or an oral glucose tolerance test, potentially missing additional effects. Baseline differences in insulin and insulin resistance could have introduced residual confounding. The small effect size also questions long-term clinical relevance.
- Metabolomics hint: A preliminary array linked magnesium supplementation with changes in 52 blood metabolites, especially related to lipid metabolism and insulin resistance. However, given the exploratory nature and tentative metabolite identifications, these findings should be viewed as hypothesis-generating.
Implications and next steps
This study shows that in older adults with prediabetes and magnesium deficiency, magnesium supplementation can meaningfully raise serum magnesium and slightly lower fasting glucose, but it does not provide strong evidence for a broad, multi-faceted improvement in overall glucose metabolism over the study period. The results strongly suggest a need for larger, longer trials that compare different magnesium formulations and examine dose–response effects. Such studies should incorporate diverse glycemic measures (including postprandial glucose and OGTT) and longer follow-up to determine whether modest fasting glucose reductions can translate into meaningful clinical benefits.
Bottom line
Magnesium supplementation appears to offer a targeted metabolic benefit for a specific group—older adults with prediabetes and hypomagnesemia—by correcting magnesium deficiency and modestly lowering fasting glucose. Yet, on its own, it is unlikely to halt diabetes progression without additional interventions or longer-term evidence. The broader question remains: how should magnesium supplementation fit into a comprehensive prevention strategy for prediabetes and diabetes in aging populations?
Would you like to see this rewritten with a stronger emphasis on practical takeaways for readers or adapted into a quick, shareable summary for social media? And do you prefer a more cautious or a more provocative framing to stimulate discussion in comments?
